Skip to main navigation Skip to search Skip to main content

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

  • on behalf of the
  • , ISN Global Kidney Health Summit participants
  • , ISN Global Kidney Health Summit participants
  • University of British Columbia
  • University of Calgary
  • Harvard University
  • Johns Hopkins University
  • International Society of Nephrology
  • Vanderbilt University
  • Merck
  • University of Groningen
  • The George Institute for Global Health
  • Concord Repatriation General Hospital
  • Hennepin County Medical Center
  • University of Minnesota Twin Cities
  • University of Freiburg
  • University of Michigan, Ann Arbor
  • Tufts University
  • University of Zurich
  • University of California at San Diego
  • University of Texas Southwestern Medical Center
  • Universidad Panamericana (UP)
  • University of Alberta
  • Yale University
  • Department of Veterans Affairs
  • University of Sydney
  • Kolling Institute of Medical Research
  • Karolinska Institutet
  • University of Washington
  • University College London
  • Friedrich-Alexander University Erlangen-Nürnberg

Research output: Contribution to journal › Review article › peer-review

821 Scopus citations

Abstract

The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

Original languageEnglish
Pages (from-to)1888-1917
Number of pages30
JournalThe Lancet
Volume390
Issue number10105
DOIs
StatePublished - 21 Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy'. Together they form a unique fingerprint.

Cite this